Malignant neoplasm of connective and soft tissue of lower limb, including hip
ICD-10 C49.2 is a billable code used to indicate a diagnosis of malignant neoplasm of connective and soft tissue of lower limb, including hip.
C49.2 refers to malignant neoplasms originating from connective and soft tissues in the lower limb, including the hip region. These tumors, known as soft tissue sarcomas, can arise from various tissues such as muscle, fat, nerves, and blood vessels. Soft tissue sarcomas are relatively rare, accounting for approximately 1% of all adult cancers. They can be classified into several subtypes, including liposarcoma, leiomyosarcoma, and synovial sarcoma, each with distinct histological features and clinical behaviors. The grading of these tumors is crucial, as it helps determine prognosis and treatment strategies. Grading is typically based on histological examination, assessing factors such as cellularity, pleomorphism, and mitotic activity. Multidisciplinary management is essential for optimal outcomes, involving surgical resection, chemotherapy, and radiation therapy, tailored to the tumor type, grade, and stage. Early diagnosis and intervention are critical, as these tumors can metastasize to distant sites if not treated promptly.
Detailed pathology reports, treatment plans, and follow-up notes are essential.
Diagnosis and treatment planning for various soft tissue sarcomas.
Ensure accurate grading and staging are documented to guide treatment.
Operative reports detailing the extent of resection and margins.
Surgical intervention for tumor resection and reconstruction.
Documenting the surgical approach and any complications is critical.
Used when excising a soft tissue sarcoma from the lower limb.
Operative report detailing the excision and margins.
Ensure the surgical approach is documented.
Grading helps determine the aggressiveness of the tumor and guides treatment decisions. Higher-grade tumors are typically more aggressive and may require more intensive treatment.
